血液凝固的增加与动脉瘤下arachnoid 出血的不良神经结果有关
Essi Raatikainen1, Heikki Kiiski1, Anne Kuitunen1
1Tampere University Hospital, Department of Intensive Care, Tampere, Finland; Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland.
Journal of the neurological sciences
|February 29, 2024
概括
患有神经瘤下关节出血的患者表现出血凝的增加,特别是那些神经结果较差的人. 然而,在本研究中,这种高凝血性与延迟脑缺血无关.
科学领域:
- 神经科学是一个神经科学.
- 血液学 血液学 血液学
- 关键护理医学 关键护理医学
背景情况:
- 动脉瘤下arachnoid出血 (aSAH) 与高凝固性有关.
- 这种增加的血液凝结可能会导致脑缺血延迟 (DCI) 和患者的不良结果.
研究的目的:
- 为了研究通过旋转血栓形成显微镜 (ROTEM) 测量血凝增加与DCI以及aSAH患者的神经结果之间的关联.
主要方法:
- 一项前性观察性研究包括60名成人aSAH患者.
- 在多个出血后的时间点分析了ROTEM测定 (EXTEM,FIBTEM) 和D-二次体水平.
- 在三个月后,使用扩展格拉斯哥结果表 (GOSe) 评估神经结果.
主要成果:
- 患有不良神经结果的患者在特定的出血后几天表现出更短的EXTEM凝块形成时间和更高的FIBTEM最大凝块牢固度.
- 在整个研究期间,在不良结果的患者中观察到更高的D-二聚合物水平.
- 在ROTEM参数或D-二次元水平与DCI发生率之间没有发现显著的关联.
结论:
- 在aSAH患者中存在增加的血液凝固,与较差的神经结果相关.
- 通过ROTEM评估的高凝血性,在这个队列中没有发现与DCI的发展有关.
关键词:
动脉瘤下arachnoid出血 动脉瘤下arachnoid出血 动脉瘤下arachnoid出血 动脉瘤下arachnoid出血血液凝固 血液凝固延迟的大脑缺血症 延迟的大脑缺血在重症监护病房的重症监护病房.结果结果的结果.更多相关视频
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
696
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
696
Disorders of Hemostasis
904
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
904
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K


